World Health Organization Issues Warning Over Critical Scarcity of Obesity Medications
Under a tenth of people that would benefit from weight-loss injections such as Wegovy have access to them, caution the global health agency as it issues its first guidance on the medications.
Considering more than one billion people worldwide currently living with obesity, it is calling for broader and more equitable availability to GLP-1 medication.
Per forecasts, more than two billion will be living with obesity by 2030 if no action is taken.
"Our new guidelines affirms that excess weight is a chronic disease that can be addressed with comprehensive and ongoing support," remarked WHO director-general Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and distribution challenges are significant barriers to universal access to the injections that can assist patients in reducing substantial body mass, explains the body.
Weight-Loss Drug Shortage
Even in the present most favorable scenario, the supply of GLP-1 therapies could only cover about 100 million people – less than 10% of those who need them, per the WHO.
The recommendation encourages nations and manufacturers to increase availability, through approaches including patent sharing.
Exclusive production rights on semaglutide – the core component of Novo Nordisk's Wegovy – is due to expire in a number of countries in 2026.
The Way Weight-Loss Drugs Function
GLP-1 drugs imitate a biological compound to reduce digestion speed, curb appetite and increase feelings of fullness so users eat less.
Individuals usually see weight reduction in the initial weeks of commencing the regular doses.
Studies points to users may see weight return a year later of halting the drug, because their typical food cravings return.
To be above a healthy weight increases your chance for developing medical conditions, such as type 2 diabetes, cardiovascular issues, stroke, and some malignancies.
Obesity affects individuals in countries worldwide and was associated with over three and a half million fatalities worldwide in 2024, according to the WHO.
